Crinetics Pharmaceuticals, Inc. (CRNX)

USD 52.09

(-5.92%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 635.35 Million 352.17 Million 351.01 Million 183.44 Million 130.37 Million 171.41 Million
Total Current Assets 574.15 Million 345.18 Million 344.72 Million 177.49 Million 123.33 Million 166.68 Million
Cash And Short Term Investments 558.55 Million 334.42 Million 333.7 Million 170.88 Million 118.39 Million 163.87 Million
Cash and Cash Equivalents 54.89 Million 32.67 Million 200.69 Million 93.08 Million 40.32 Million 44.97 Million
Short Term Investments 503.65 Million 301.75 Million 133.01 Million 77.79 Million 78.06 Million 118.9 Million
Net Receivables 9.35 Million 2.42 Million 2.02 Million 1.83 Million 1.37 Million 1.58 Million
Inventory - - 8.07 Million -1.83 Million -1.37 Million -
Other Current Assets 6.24 Million 8.33 Million 912 Thousand 6.61 Million 4.94 Million 1.22 Million
Total Non-Current Assets 61.19 Million 6.99 Million 6.29 Million 5.95 Million 7.03 Million 4.73 Million
Net PPE 57.43 Million 4.98 Million 4.71 Million 5.41 Million 6.45 Million 4.23 Million
Good Will And Intangible Assets - - - - - -
Good Will - - - - - -
Intangible Assets - - - - - -
Long-Term Investments 1.77 Million 1.96 Million 1.01 Million 500 Thousand 500 Thousand 500 Thousand
Tax Assets - - - - - -
Other Non Current Assets 1.99 Million 37 Thousand 568 Thousand 40 Thousand 82 Thousand -
Other Assets 1.00 - - - - -
Total Liabilities 96.24 Million 35.84 Million 19.07 Million 14.52 Million 13.23 Million 11.19 Million
Total Current Liabilities 43.94 Million 27.72 Million 15.99 Million 10.48 Million 8.34 Million 7.92 Million
Account Payables 6.54 Million 6.88 Million 8.46 Million 5.58 Million 5.49 Million 1.45 Million
Tax Payables - - - - - -
Short Term Debt 4.17 Million 1.05 Million 939 Thousand 835 Thousand 724 Thousand -
Deferred Revenue 2.05 Million 2.24 Million -939 Thousand -835 Thousand -724 Thousand -
Other Current Liabilities 31.16 Million 17.54 Million 7.52 Million 4.9 Million 2.84 Million 6.46 Million
Total Non Current Liabilities 52.3 Million 8.12 Million 3.07 Million 4.03 Million 4.89 Million 3.26 Million
Long-Term Debt 47.55 Million 2.02 Million 3.07 Million 4.01 Million 4.84 Million -
Deferred Revenue Non Current 4.75 Million 6.1 Million - - - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 47.55 Million 6.1 Million 2000.00 23 Thousand 49 Thousand 3.26 Million
Other Liabilities - - - - - -
Total Equity 539.1 Million -439.17 Million -275.25 Million -167.61 Million -93.8 Million -43.38 Million
Stock Holders Equity 539.1 Million -439.17 Million -275.25 Million -167.61 Million -93.8 Million -43.38 Million
Common Stock 1.19 Billion 759.43 Million 607.58 Million 336.5 Million 210.79 Million 24 Thousand
Retained Earnings -653.7 Million -439.17 Million -275.25 Million -167.61 Million -93.8 Million -43.38 Million
Accumulated other comprehensive income 977 Thousand -3.93 Million -382 Thousand 25 Thousand 148 Thousand 61 Thousand
Common Stock Equity 539.1 Million -439.17 Million -275.25 Million -167.61 Million -93.8 Million -43.38 Million
Capital Lease Obligation 47.55 Million 2.02 Million 3.07 Million 4.01 Million 4.84 Million -
Total Investments 505.42 Million 301.75 Million 134.02 Million 77.79 Million 78.06 Million 118.9 Million
Total Debt 51.72 Million 2.02 Million 3.07 Million 4.01 Million 4.84 Million -
Net Debt -3.16 Million -30.64 Million -197.62 Million -89.07 Million -35.47 Million -44.97 Million

Balance Sheet Charts